Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.

Gaidukov L, Viji RI, Yacobson S, Rosenblat M, Aviram M, Tawfik DS.

Biochemistry. 2010 Jan 26;49(3):532-8. doi: 10.1021/bi9013227.

PMID:
20025294
2.
3.

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux.

Gaidukov L, Rosenblat M, Aviram M, Tawfik DS.

J Lipid Res. 2006 Nov;47(11):2492-502. Epub 2006 Aug 16.

4.

Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.

Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.

Circ Res. 2004 Oct 15;95(8):789-97. Epub 2004 Sep 23.

5.
6.

HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.

Moren X, Deakin S, Liu ML, Taskinen MR, James RW.

J Lipid Res. 2008 Jun;49(6):1246-53. doi: 10.1194/jlr.M700439-JLR200. Epub 2008 Feb 26.

7.

Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.

Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, Rust S, Assmann G, Anantharamaiah GM, Palgunachari MN, Katz SL, Phillips MC, Dean RT, Jessup W, Kritharides L.

J Biol Chem. 2004 Jun 18;279(25):25966-77. Epub 2004 Apr 1.

8.
9.

Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.

Kar S, Patel MA, Tripathy RK, Bajaj P, Pande AH.

Biochim Biophys Acta. 2013 Dec;1831(12):1714-20. doi: 10.1016/j.bbalip.2013.08.008. Epub 2013 Aug 23.

PMID:
23973798
10.

Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.

Noto H, Hashimoto Y, Satoh H, Hara M, Iso-o N, Togo M, Kimura S, Tsukamoto K.

Biochem Biophys Res Commun. 2001 Nov 30;289(2):395-401.

PMID:
11716486
11.

Macrophage paraoxonase 1 (PON1) binding sites.

Efrat M, Aviram M.

Biochem Biophys Res Commun. 2008 Nov 7;376(1):105-10. doi: 10.1016/j.bbrc.2008.08.106. Epub 2008 Aug 30.

PMID:
18762170
12.

Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.

Lee M, Calabresi L, Chiesa G, Franceschini G, Kovanen PT.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1475-81.

13.

Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.

Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS.

J Lipid Res. 2003 Apr;44(4):780-92. Epub 2003 Jan 16.

14.
15.

Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity.

Oda MN, Bielicki JK, Berger T, Forte TM.

Biochemistry. 2001 Feb 13;40(6):1710-8.

PMID:
11327831
16.

Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells.

Thurberg BL, Reardon CA, Getz GS.

J Biol Chem. 1996 Mar 15;271(11):6062-70.

17.

Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.

Hedrick CC, Hassan K, Hough GP, Yoo JH, Simzar S, Quinto CR, Kim SM, Dooley A, Langi S, Hama SY, Navab M, Witztum JL, Fogelman AM.

Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1946-52.

18.

Distribution spectrum of paraoxonase activity in HDL fractions.

Bergmeier C, Siekmeier R, Gross W.

Clin Chem. 2004 Dec;50(12):2309-15. Epub 2004 Sep 30.

19.

Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.

de Beer MC, Durbin DM, Cai L, Mirocha N, Jonas A, Webb NR, de Beer FC, van Der Westhuyzen DR.

J Biol Chem. 2001 May 11;276(19):15832-9. Epub 2001 Feb 9.

Supplemental Content

Support Center